Implantables, commonly known as prosthetics, are medical devices which are used to replace missing or abnormal body parts or organs. Various biomaterials are used for the development of implants such as metals, polymers, ceramics, and composites. The choice of material for implant development depends on application area, duration of implantation, biochemical properties of the material, and the material’s impact on tissues in the vicinity. Polymers have been used in the development of implants as these offer biocompatibility, tissue regeneration, flexibility, and strength. Polymers are widely used in orthopedic, esthetic, and cardiovascular implants beside which they are also been considered in implantable drug delivery devices for target specific drug delivery for the treatment of cancer and other disease indications.
Polymers are used in the development of orthopedic implants such as spine implants, spinal spacers and discs, joint replacement implants, tendons, and ligaments. Increasing geriatric population is estimated to drive the demand for polymer-based orthopedic implants. It is estimated that more than 50% of orthopedic implants are used in patients aged 65 years and above. Moreover, with increasing demand for esthetics, the consumption of esthetic implants such as silicone-based breast implants and maxillofacial implants is projected to grow. Polymers are also used in cardiovascular implants such as drug eluting stents and artificial heart valves. According to an independent study conducted in the U.S., about 75% of coronary stents deployed in the U.S. was polymer-based drug eluting stents. Increase in the prevalence of cardiovascular diseases is expected to drive the growth of the polymer implantables market during the forecast period. However, there have been few adverse events in the recent years regarding the esthetic implants made with silicone, which has hampered the market growth. Additionally, inappropriate selection of materials, low-quality raw materials, and high cost of implants are the concerned areas of the polymer implantables market, which are estimated to restrain the market growth during the forecast period.
The global polymer implantables market is segmented on the basis of product, material, end-user, and region. In terms of product, the market can be segmented into orthopedic implants, cardiovascular implants, esthetic implants, dental implants, and others. The orthopedic implants segment can be classified into joint replacement implants and spinal implants. The others segment includes soft tissue repair products, hernia meshes, and surgical sutures. Growing incidence of cardiovascular diseases is estimated to drive the growth of the cardiovascular implants segment. On the basis of material, the market is segmented into polyethylene, silicone, polyurethane, polyketone, fluoropolymer, and others. The others segment includes bio absorbable polymers such as polylactic acid (PLA), polyglycolic acid (PGA), and polycaprolactone (PCL). Polyketone, such as PEEK, and polyethylene, such as ultra-high molecular weight polyethylene (UHMWPE) and high density polyethylene (HDPE), are widely used in the development of orthopedic implants. These two segments are projected to expand at a high growth rate during the forecast period. On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers (ASC), and others. Increasing base of ASCs and rising preference for minimally invasive procedures are estimated to drive the segment growth during the forecast period.
In terms of region, the global market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to hold a significant share of the global market due to high adoption of technology and increased health care expenditure. Europe is estimated to hold a prominent share of the global market and is anticipated to expand at a prominent growth rate, due to increasing geriatric population and developing healthcare infrastructure.
Major players operating in the global polymer implantables market include Boston Scientific Corporation, Smith & Nephew plc, Stryker Corporation, Zimmer Biomet Holdings, Inc., Edwards Lifesciences Corporation, Abbott Laboratories, Terumo Corporation, Medtronic plc, Johnson & Johnson, and Straumann Holding AG.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.